Vita Dolžan

7.7k total citations · 1 hit paper
210 papers, 3.7k citations indexed

About

Vita Dolžan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vita Dolžan has authored 210 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 43 papers in Pulmonary and Respiratory Medicine and 34 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vita Dolžan's work include Occupational and environmental lung diseases (35 papers), Pharmacogenetics and Drug Metabolism (20 papers) and Acute Lymphoblastic Leukemia research (18 papers). Vita Dolžan is often cited by papers focused on Occupational and environmental lung diseases (35 papers), Pharmacogenetics and Drug Metabolism (20 papers) and Acute Lymphoblastic Leukemia research (18 papers). Vita Dolžan collaborates with scholars based in Slovenia, Italy and United States. Vita Dolžan's co-authors include Katja Goričar, Andrej Janež, Petra Bohanec Grabar, Janez Jazbec, Viljem Kovač, Jasna Klen, Katja Breskvar, Mojca Jensterle, Iztok Grabnar and D Logar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vita Dolžan

202 papers receiving 3.6k citations

Hit Papers

Metformin and Insulin Resistance: A Review of the Underly... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport
    2022 156 citations Vita Dolžan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vita Dolžan Slovenia 33 1.3k 585 505 446 404 210 3.7k
Oliver Zolk Germany 42 1.5k 1.2× 299 0.5× 359 0.7× 345 0.8× 687 1.7× 109 4.6k
Karina Braga Gomes Brazil 31 850 0.7× 294 0.5× 431 0.9× 90 0.2× 461 1.1× 194 3.8k
Robert Schmouder United States 32 2.2k 1.7× 740 1.3× 119 0.2× 215 0.5× 268 0.7× 93 5.4k
Raymond Ardaillou France 42 1.9k 1.5× 280 0.5× 1.0k 2.1× 235 0.5× 301 0.7× 260 6.0k
Allison B. Reiss United States 38 1.6k 1.3× 133 0.2× 358 0.7× 206 0.5× 81 0.2× 118 4.8k
Masayoshi Soma Japan 34 1.4k 1.1× 123 0.2× 1.3k 2.6× 202 0.5× 208 0.5× 256 4.6k
Jer‐Yuarn Wu Taiwan 26 948 0.7× 93 0.2× 323 0.6× 590 1.3× 305 0.8× 85 4.0k
Atsushi Yonezawa Japan 30 1.1k 0.8× 204 0.3× 124 0.2× 243 0.5× 830 2.1× 126 3.8k
Daniele Cusi Italy 37 1.7k 1.3× 172 0.3× 1.6k 3.1× 230 0.5× 378 0.9× 162 4.9k
Clive R. Pullinger United States 40 1.7k 1.4× 151 0.3× 1.5k 2.9× 208 0.5× 210 0.5× 122 6.0k

Countries citing papers authored by Vita Dolžan

Since Specialization
Citations

This map shows the geographic impact of Vita Dolžan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vita Dolžan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vita Dolžan more than expected).

Fields of papers citing papers by Vita Dolžan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vita Dolžan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vita Dolžan. The network helps show where Vita Dolžan may publish in the future.

Co-authorship network of co-authors of Vita Dolžan

This figure shows the co-authorship network connecting the top 25 collaborators of Vita Dolžan. A scholar is included among the top collaborators of Vita Dolžan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vita Dolžan. Vita Dolžan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mlinšek, Gregor, et al.. (2025). Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment of Slovenian patients undergoing kidney transplantation in the U-PGx PREPARE study. The Pharmacogenomics Journal. 25(1-2). 6–6. 1 indexed citations
2.
3.
Swen, Jesse J., Alfons A den Broeder, Johanna M W Hazes, et al.. (2023). Genome‐wide Association Study of Methotrexate‐Induced Liver Injury in Rheumatoid Arthritis Patients. Clinical Pharmacology & Therapeutics. 113(4). 916–923. 2 indexed citations
4.
5.
Dolžan, Vita, et al.. (2022). Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity. Biology. 11(2). 178–178. 3 indexed citations
6.
Goričar, Katja, et al.. (2021). The role of polymorphisms in glutathione-related genes in asbestos-related diseases. Radiology and Oncology. 55(2). 179–186. 1 indexed citations
7.
Štrbac, Danijela, et al.. (2021). Serum Calretinin as a Biomarker in Malignant Mesothelioma. Journal of Clinical Medicine. 10(21). 4875–4875. 5 indexed citations
8.
Goričar, Katja, et al.. (2020). The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma. Radiology and Oncology. 54(4). 429–436. 4 indexed citations
9.
Goričar, Katja, et al.. (2020). Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases. Radiology and Oncology. 54(1). 86–95. 14 indexed citations
10.
Goričar, Katja, et al.. (2019). The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma. Radiology and Oncology. 53(2). 206–212. 6 indexed citations
11.
Goričar, Katja, et al.. (2019). Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment. Radiology and Oncology. 53(1). 96–104. 6 indexed citations
12.
Dolžan, Vita, et al.. (2018). From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms. OMICS A Journal of Integrative Biology. 22(1). 1–16. 36 indexed citations
13.
Štrbac, Danijela, Katja Goričar, Vita Dolžan, & Viljem Kovač. (2018). Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma. Radiology and Oncology. 52(2). 160–166. 9 indexed citations
14.
Goričar, Katja, et al.. (2018). The influence of genetic variability on the risk of developing malignant mesothelioma. Radiology and Oncology. 52(1). 105–111. 12 indexed citations
15.
Zukić, Branka, Biljana Stanković, Dragana Janić, et al.. (2018). Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. Radiology and Oncology. 52(3). 296–306. 16 indexed citations
16.
Goričar, Katja, et al.. (2015). Homologous recombination repair polymorphisms and the risk for osteosarcoma. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Goričar, Katja, Viljem Kovač, & Vita Dolžan. (2014). Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma. Radiology and Oncology. 48(2). 163–172. 13 indexed citations
18.
Kotnik, Barbara Faganel, et al.. (2013). The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma. Radiology and Oncology. 48(3). 289–292. 14 indexed citations
19.
20.
Dolžan, Vita, et al.. (2003). GENETIC POLYMORPHISM OF CYTOCHROMES P450 2C9 AND 2C19 IN SLOVENIAN POPULATION. SHILAP Revista de lepidopterología. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Zolk Breakdown of academic impact, for papers by Karina Braga Gomes Breakdown of academic impact, for papers by Robert Schmouder Breakdown of academic impact, for papers by Raymond Ardaillou Breakdown of academic impact, for papers by Allison B. Reiss Breakdown of academic impact, for papers by Masayoshi Soma Breakdown of academic impact, for papers by Jer‐Yuarn Wu Breakdown of academic impact, for papers by Atsushi Yonezawa Breakdown of academic impact, for papers by Daniele Cusi Breakdown of academic impact, for papers by Clive R. Pullinger
Rankless by CCL
2026